Agilent Technologies EBITDA Margin 2010-2025 | A
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Agilent Technologies (A) over the last 10 years. The current EBITDA margin for Agilent Technologies as of April 30, 2025 is .
| Agilent Technologies EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-04-30 | $6.63B | $1.69B | 25.56% |
| 2025-01-31 | $6.53B | $1.75B | 26.74% |
| 2024-10-31 | $6.51B | $1.75B | 26.80% |
| 2024-07-31 | $6.50B | $1.74B | 26.75% |
| 2024-04-30 | $6.59B | $1.55B | 23.46% |
| 2024-01-31 | $6.74B | $1.57B | 23.37% |
| 2023-10-31 | $6.83B | $1.62B | 23.72% |
| 2023-07-31 | $6.99B | $1.70B | 24.24% |
| 2023-04-30 | $7.04B | $1.98B | 28.15% |
| 2023-01-31 | $6.93B | $1.97B | 28.43% |
| 2022-10-31 | $6.85B | $1.94B | 28.26% |
| 2022-07-31 | $6.66B | $1.87B | 28.08% |
| 2022-04-30 | $6.53B | $1.80B | 27.56% |
| 2022-01-31 | $6.45B | $1.72B | 26.72% |
| 2021-10-31 | $6.32B | $1.67B | 26.40% |
| 2021-07-31 | $6.14B | $1.56B | 25.46% |
| 2021-04-30 | $5.82B | $1.45B | 24.94% |
| 2021-01-31 | $5.53B | $1.26B | 22.86% |
| 2020-10-31 | $5.34B | $1.15B | 21.61% |
| 2020-07-31 | $5.22B | $1.11B | 21.16% |
| 2020-04-30 | $5.24B | $1.08B | 20.59% |
| 2020-01-31 | $5.24B | $1.17B | 22.33% |
| 2019-10-31 | $5.16B | $1.18B | 22.84% |
| 2019-07-31 | $5.09B | $1.15B | 22.65% |
| 2019-04-30 | $5.02B | $1.15B | 22.85% |
| 2019-01-31 | $4.99B | $1.14B | 22.82% |
| 2018-10-31 | $4.91B | $1.11B | 22.67% |
| 2018-07-31 | $4.81B | $1.07B | 22.15% |
| 2018-04-30 | $4.72B | $1.04B | 22.10% |
| 2018-01-31 | $4.62B | $1.04B | 22.49% |
| 2017-10-31 | $4.47B | $1.02B | 22.79% |
| 2017-07-31 | $4.39B | $1.01B | 22.92% |
| 2017-04-30 | $4.32B | $0.96B | 22.22% |
| 2017-01-31 | $4.24B | $0.90B | 21.24% |
| 2016-10-31 | $4.20B | $0.86B | 20.49% |
| 2016-07-31 | $4.13B | $0.84B | 20.31% |
| 2016-04-30 | $4.10B | $0.84B | 20.46% |
| 2016-01-31 | $4.04B | $0.81B | 20.12% |
| 2015-10-31 | $4.04B | $0.78B | 19.19% |
| 2015-07-31 | $4.81B | $0.81B | 16.89% |
| 2015-04-30 | $4.80B | $0.83B | 17.22% |
| 2015-01-31 | $4.83B | $0.85B | 17.56% |
| 2014-10-31 | $4.81B | $0.89B | 18.40% |
| 2014-07-31 | $4.72B | $1.01B | 21.43% |
| 2014-04-30 | $5.37B | $1.12B | 20.83% |
| 2014-01-31 | $6.11B | $1.23B | 20.16% |
| 2013-10-31 | $6.78B | $1.32B | 19.51% |
| 2013-07-31 | $6.83B | $1.32B | 19.25% |
| 2013-04-30 | $6.90B | $1.34B | 19.44% |
| 2013-01-31 | $6.90B | $1.40B | 20.25% |
| 2012-10-31 | $6.86B | $1.42B | 20.71% |
| 2012-07-31 | $6.82B | $1.42B | 20.88% |
| 2012-04-30 | $6.79B | $1.41B | 20.83% |
| 2012-01-31 | $6.73B | $1.38B | 20.55% |
| 2011-10-31 | $6.62B | $1.32B | 20.02% |
| 2011-07-31 | $6.46B | $1.22B | 18.85% |
| 2011-04-30 | $6.16B | $1.05B | 17.04% |
| 2011-01-31 | $5.75B | $0.91B | 15.81% |
| 2010-10-31 | $5.44B | $0.77B | 14.11% |
| 2010-07-31 | $5.04B | $0.61B | 12.10% |
| 2010-04-30 | $4.71B | $0.47B | 10.07% |
| 2010-01-31 | $4.53B | $0.28B | 6.12% |
| 2009-10-31 | $4.48B | $0.21B | 4.66% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.381B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $215.166B | 25.24 |
| Boston Scientific (BSX) | United States | $153.330B | 38.38 |
| Stryker (SYK) | United States | $148.630B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $131.070B | 0.00 |
| Medtronic (MDT) | Ireland | $114.929B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.764B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.126B | 24.61 |
| ResMed (RMD) | United States | $37.818B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $34.781B | 16.51 |
| Terumo (TRUMY) | Japan | $23.911B | 31.06 |
| Koninklijke Philips (PHG) | Netherlands | $23.688B | 16.62 |
| Insulet (PODD) | United States | $20.003B | 78.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.437B | 11.84 |
| Baxter (BAX) | United States | $14.251B | 10.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.214B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.705B | 23.33 |
| Lantheus Holdings (LNTH) | United States | $4.855B | 12.25 |
| Prestige Consumer Healthcare (PBH) | United States | $3.744B | 16.73 |
| Perrigo (PRGO) | Ireland | $3.706B | 9.39 |
| Haemonetics (HAE) | United States | $3.485B | 15.88 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.307B | 27.48 |
| ICU Medical (ICUI) | United States | $3.014B | 22.23 |
| LeMaitre Vascular (LMAT) | United States | $1.802B | 40.29 |
| QuidelOrtho (QDEL) | United States | $1.721B | 11.84 |
| AtriCure (ATRC) | United States | $1.449B | 0.00 |
| Acuren (TIC) | United States | $1.408B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Phibro Animal Health (PAHC) | United States | $1.192B | 15.24 |
| Green Thumb Industries (GTBIF) | United States | $1.190B | 26.76 |
| Neogen (NEOG) | United States | $1.029B | 13.17 |
| BioLife Solutions (BLFS) | United States | $0.996B | 0.00 |
| InMode (INMD) | Israel | $0.878B | 8.85 |
| Kestra Medical Technologies (KMTS) | United States | $0.816B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.625B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.619B | 0.00 |
| Owens & Minor (OMI) | United States | $0.599B | 4.97 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| CeriBell (CBLL) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.557B | 0.00 |
| Surmodics (SRDX) | United States | $0.432B | 0.00 |
| SNDL (SNDL) | Canada | $0.405B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.314B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.298B | 10.97 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.267B | 0.00 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.63 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.50 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.235B | 10.68 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Brainsway (BWAY) | Israel | $0.228B | 60.45 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Canopy Growth (CGC) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.199B | 0.00 |
| Omeros (OMER) | United States | $0.197B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.149B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.80 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.52 |
| Nephros (NEPH) | United States | $0.039B | 52.07 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |